Literature DB >> 10492857

Pretreatment differences in specific symptoms and quality of life among depressed inpatients who do and do not receive electroconvulsive therapy: a hypothesis regarding why the elderly are more likely to receive ECT.

W V McCall1, W Cohen, B Reboussin, P Lawton.   

Abstract

Electroconvulsive therapy (ECT) is among the most commonly performed medical procedures requiring general anesthesia in the United States. Nevertheless, very little is known about the characteristics of depressed patients who receive ECT and how they differ from depressed patients receiving psychotropic medication. We conducted a detailed examination of demographic, clinical, and quality-of-life (QOL) measurements in a group of 90 depressed inpatients, and we then used these measurements to contrast the 31 patients who received ECT with the 59 who received alternative therapies. The ECT group did not differ from the non-ECT group in gender composition, marital status, race, education, employment status, overall severity of depression, chronicity of depression, adequacy of prehospitalization antidepressant treatment, extent of physical illness, or extent of social support. The ECT group was older. Furthermore, the ECT group had greater weight loss, worse functioning in activities of daily living (ADLs), and worse functioning in instrumental activities of daily living (IADLs). The differences in weight loss, ADL, and IADL scores disappeared after age adjustment. However, statistical adjustment for age revealed that the ECT group reported worse capacity in their daily living and role functioning than did the non-ECT group. We conclude that the decision to pursue ECT is based in part on the perceived effect of the depression on QOL, as well as the severity of specific symptoms such as weight loss. The elderly seem particularly vulnerable to depression-related functional deficits and weight loss, and this may explain why prior studies showed a differential use of ECT in the elderly.

Entities:  

Mesh:

Year:  1999        PMID: 10492857

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  4 in total

Review 1.  Neuromodulation therapies for geriatric depression.

Authors:  Verònica Gálvez; Kerrie-Anne Ho; Angelo Alonzo; Donel Martin; Duncan George; Colleen K Loo
Journal:  Curr Psychiatry Rep       Date:  2015-07       Impact factor: 5.285

2.  Effects of a right unilateral ultrabrief pulse electroconvulsive therapy course on health related quality of life in elderly depressed patients.

Authors:  W Vaughn McCall; Sarah H Lisanby; Peter B Rosenquist; Mary Dooley; Mustafa M Husain; Rebecca G Knapp; Georgios Petrides; Matthew V Rudorfer; Robert C Young; Shawn M McClintock; Martina Mueller; Joan Prudic; Robert M Greenberg; Richard D Weiner; Samuel H Bailine; Mary Anne Riley; Laryssa McCloud; Charles H Kellner
Journal:  J Affect Disord       Date:  2016-11-11       Impact factor: 4.839

3.  Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT.

Authors:  W Vaughn McCall; David Reboussin; Joan Prudic; Roger F Haskett; Keith Isenberg; Mark Olfson; Peter B Rosenquist; Harold A Sackeim
Journal:  J Affect Disord       Date:  2012-11-15       Impact factor: 4.839

4.  Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: A randomized clinical trial.

Authors:  W Vaughn McCall; Sarah H Lisanby; Peter B Rosenquist; Mary Dooley; Mustafa M Husain; Rebecca G Knapp; Georgios Petrides; Matthew V Rudorfer; Robert C Young; Shawn M McClintock; Martina Mueller; Joan Prudic; Robert M Greenberg; Richard D Weiner; Samuel H Bailine; Nagy A Youssef; Laryssa McCloud; Charles H Kellner
Journal:  J Psychiatr Res       Date:  2017-11-16       Impact factor: 4.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.